REQUEST A DEMO
Total
USD $0.00
Search more companies

Gongwin Biopharm Holdings Co., Ltd. (共信医药科技控股股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in Nanotechnology
Full name: Gongwin Biopharm Holdings Co., Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Gongwin Biopharm Holdings Co., Ltd is a biotechnology pharmaceutical company. The company focuses on developing new anticancer drugs for both human and animal cancer treatment. Gongwin has developed a product for Companion Animal Cancer Treatment, with potential to treat canine solid cancer tumors. Since 2019, the company has been conducting research and development for animal cancer drugs and has initiated pre-field trials to explore the response in different pet animal cancer types.

Headquarters
3F, No. 80, Sec. 1, Jianguo North Road, Zongshan Dist
Taipei City; Taipei City;

Contact Details: Purchase the Gongwin Biopharm Holdings Co., Ltd. (共信医药科技控股股份有限公司) report to view the information.

Website: http://www.gongwinbiopharm.com

Basic Information
Total Employees:
Purchase the Gongwin Biopharm Holdings Co., Ltd. (共信医药科技控股股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Gongwin Biopharm Holdings Co., Ltd. (共信医药科技控股股份有限公司) report to view the information.
Financial Auditors:
Purchase the Gongwin Biopharm Holdings Co., Ltd. (共信医药科技控股股份有限公司) report to view the information.
Incorporation Date:
March 27, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
19.12%
Purchase this report to view the information.
14.44%
Purchase this report to view the information.
6.2%
Purchase this report to view the information.
5.27%
Purchase this report to view the information.
2.2%
Subsidiaries
Pts International Inc. (United States)
100%
共信醫藥科技股份有限公司
100%
Company Performance
Financial values in the chart are available after Gongwin Biopharm Holdings Co., Ltd. (共信医药科技控股股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
23.46%
Total operating revenue
20.85%
Operating Profit/Loss (EBIT)
-31.2%
EBITDA
-41.5%
Net Profit/Loss for the Period
-7.39%
Total Assets
-19.8%
Total Equity
-21.31%
Operating Profit Margin (ROS)
-25.63%
Net Profit Margin
36.74%
Return on Equity (ROE)
-0.74%
Debt/Equity
0.86%
Quick Ratio
-4.33%
Cash Ratio
0.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?